Concepedia

Suzanne Demko

SD

Statistics

Publications

5

Citations

452

H-Index

5

Active since

2008

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Suzanne Demko is an author at United States Food and Drug Administration specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2008–2021

5

Publications

5

FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma

Denise Casey, Suzanne Demko, Stacy S. Shord et al. · Clinical Cancer Research · 2017 · 129 citations · Full text

, , +7

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Denise Casey, Suzanne Demko, A. K. Sinha et al. · Clinical Cancer Research · 2021 · 107 citations

, , +12

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Suzanne Demko, Jeffrey Summers, Patricia Keegan et al. · The Oncologist · 2008 · 94 citations · Full text

, , +13

U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma

Thomas M. Herndon, Suzanne Demko, Xiaoping Jiang et al. · The Oncologist · 2012 · 87 citations · Full text

, , +17

FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma

Diana Bradford, Suzanne Demko, Susan Jin et al. · The Oncologist · 2020 · 35 citations · Full text

, , +17

1–5 of 5